Lixte Biotechnology H -CW25LIXTWPreferred / convertible
13F holders, Q4 2024 (December 31)2holders −1
0new positions
1sold out
1famous investor
$0.03avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Lixte Biotechnology H -CW25 (LIXTW) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($793) and Clear Street LLC ($650). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Lixte Biotechnology H -CW25
- CUSIP
- 539319111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
All 13F filers, Q3 2024 → Q4 2024: 36,715 shares sold, net −36,715 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -2.9% | 27,332 | $793 |
| Clear Street LLC | — | No change | 22,554 | $650 |
"% of holder's portfolio" is LIXTW's weight in each manager's 13F, not the share of Lixte Biotechnology H -CW25 the manager owns.